Fundraising Fox
Michael Gladstone
InvestorPartner at Atlas Venture
Boston, Massachusetts
Writes $10M – $50M checks · typically $25M
Find your path to Michael
Sign up to see every warm intro you have to Michael
- Paths you didn't know you had: your email and LinkedIn already hold routes to Michael. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Michael Gladstone is a partner at Atlas Venture, which he joined in 2012, and works on forming new therapeutics companies. Before Atlas, he worked at L.E.K. Consulting on business development and corporate strategy for biopharma clients, and earlier led HIV vaccine research in the Viral Pathogenesis department at Beth Israel Deaconess Medical Center. He holds an AB in biochemical sciences from Harvard College.
Contact· self-published, not guessed
Invests in
Biotech
Deals · 1
Caldera Therapeutics, Inc.Board seat
via Atlas Venture · filed Jan 2026 · $37.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Aiolos BioAkeroAkriveia TherapeuticsAvroBioCaldera TherapeuticsDay One BiopharmaceuticalsDay One BiopharmaceuticalsDeliniaDiagonal TherapeuticsEthyreal BioIFM Therapeutics LLCKailera TherapeuticsObsidian TherapeuticsPheon TherapeuticsReplimuneThird Harmonic BioVersanis BioXilio Therapeutics
Investor
Day One BiopharmaceuticalsDiagonal TherapeuticsEthyreal BioPheon TherapeuticsSAPISpero TherapeuticsSurface OncologyThird Harmonic BioVersanis Bio
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Atlas Venture
Frequently asked questions
- Who is Michael Gladstone?
- Michael Gladstone is a partner at Atlas Venture, which he joined in 2012, and works on forming new therapeutics companies. Before Atlas, he worked at L.E.K. Consulting on business development and corporate strategy for biopharma clients, and earlier led HIV vaccine research in the Viral Pathogenesis department at Beth Israel Deaconess Medical Center. He holds an AB in biochemical sciences from Harvard College.
- Where does Michael Gladstone work?
- Michael Gladstone is Partner at Atlas Venture.
- What does Michael Gladstone invest in?
- Michael Gladstone invests in Biotech.
- What check size does Michael Gladstone write?
- Michael Gladstone typically writes checks of $10M – $50M.
- What boards does Michael Gladstone sit on?
- Michael Gladstone holds tracked board seats at Aiolos Bio, Akero, Akriveia Therapeutics, AvroBio, Caldera Therapeutics, Caldera Therapeutics, Inc., Day One Biopharmaceuticals, Day One Biopharmaceuticals, Delinia, Diagonal Therapeutics.
- What companies has Michael Gladstone invested in?
- Investments tracked here include Day One Biopharmaceuticals, Diagonal Therapeutics, Ethyreal Bio, Pheon Therapeutics, SAPI, Spero Therapeutics, Surface Oncology, Third Harmonic Bio, Versanis Bio.
About this profile. Compiled from public sources — Atlas Venture's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights